Initial experience with a new laparoscopic ultrasound probe for guided biopsy in the staging of upper gastrointestinal cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Initial experience with a new laparoscopic ultrasound probe for guided biopsy in the staging of upper gastrointestinal cancer. / Hassan, Hazem; Vilmann, Peter; Sharma, Vijay; Holm, Jakob.
I: Surgical Endoscopy, Bind 23, Nr. 7, 2009, s. 1552-8.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Initial experience with a new laparoscopic ultrasound probe for guided biopsy in the staging of upper gastrointestinal cancer
AU - Hassan, Hazem
AU - Vilmann, Peter
AU - Sharma, Vijay
AU - Holm, Jakob
N1 - Keywords: Aged; Antineoplastic Agents; Biopsy, Fine-Needle; Carcinoma; Combined Modality Therapy; Equipment Design; Esophageal Neoplasms; Esophageal Stenosis; Esophagogastric Junction; Female; Humans; Laparoscopy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Needles; Neoplasm Invasiveness; Neoplasm Staging; Palliative Care; Pilot Projects; Prospective Studies; Stents; Stomach Neoplasms; Ultrasonography, Interventional
PY - 2009
Y1 - 2009
N2 - BACKGROUND: Until recently, laparoscopic ultrasound (LUS)-guided biopsy has been difficult with the available probes on the market. This study aimed to present a new laparoscopic ultrasound probe (Hitachi, EUP-OL531) for guided biopsy and describe its impact on the clinical outcome for patients with upper gastrointestinal (UGI) cancer. METHODS: Patients referred with confirmed UGI cancer from June 2003 to December 2006 were included in the study. After a standard workup including computed tomography, endoscopic ultrasound, and ultrasound of the neck, operable patients underwent LUS with or without fine-needle aspiration (FNA). RESULTS: From a total of 175 patients, 19 (11%) underwent LUS-guided FNA after a significant lesion was found. The LUS-guided FNA confirmed distant metastasis in 14 of the 19 patients and changed the clinical management for these 14 patients (8%). There were no adverse events due to LUS or LUS-guided FNA. CONCLUSION: The current results with the new LUS probe for guided FNA are encouraging in terms of its diagnostic ability, safety, and ease of use.
AB - BACKGROUND: Until recently, laparoscopic ultrasound (LUS)-guided biopsy has been difficult with the available probes on the market. This study aimed to present a new laparoscopic ultrasound probe (Hitachi, EUP-OL531) for guided biopsy and describe its impact on the clinical outcome for patients with upper gastrointestinal (UGI) cancer. METHODS: Patients referred with confirmed UGI cancer from June 2003 to December 2006 were included in the study. After a standard workup including computed tomography, endoscopic ultrasound, and ultrasound of the neck, operable patients underwent LUS with or without fine-needle aspiration (FNA). RESULTS: From a total of 175 patients, 19 (11%) underwent LUS-guided FNA after a significant lesion was found. The LUS-guided FNA confirmed distant metastasis in 14 of the 19 patients and changed the clinical management for these 14 patients (8%). There were no adverse events due to LUS or LUS-guided FNA. CONCLUSION: The current results with the new LUS probe for guided FNA are encouraging in terms of its diagnostic ability, safety, and ease of use.
U2 - 10.1007/s00464-009-0336-3
DO - 10.1007/s00464-009-0336-3
M3 - Journal article
C2 - 19263158
VL - 23
SP - 1552
EP - 1558
JO - Surgical Endoscopy and Other Interventional Techniques
JF - Surgical Endoscopy and Other Interventional Techniques
SN - 0930-2794
IS - 7
ER -
ID: 20341750